<DOC>
	<DOCNO>NCT01776190</DOCNO>
	<brief_summary>The investigator conduct open-label clinical trial determine effect UVA1 phototherapy cutaneous lupus ( CLE ) patient . Past research systemic lupus ( SLE ) subject indicate treatment likely effective treat cutaneous lupus side effect . The fact CLE patient see dermatology clinic also increase usefulness study large probability phototherapy treatment accessible many patient stand benefit .</brief_summary>
	<brief_title>Low-dose UVA1 Radiation Cutaneous Lupus Patients</brief_title>
	<detailed_description>Study subject receive low dose ( 20 J/cm2 ) UVA1 phototherapy treatment three time per week 10 week . Each treatment take less 30 minute . This period follow eight-week observation phase assess long term effect treatment . Patients assessed disease activity , blood study photos complete prior , , phototherapy treatment . Optional skin biopsy affect unaffected skin perform begin end active treatment phase .</detailed_description>
	<mesh_term>Lupus Erythematosus , Cutaneous</mesh_term>
	<criteria>You must 18 year old diagnosis cutaneous lupus . You must least two active area cutaneous lupus . You need come three day week 10week period . You need participate four physician visit blood draw . You diagnosis cutaneous lupus . You less two active area cutaneous lupus . You unable come three day week treatment 10week period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>